Waterloo Capital, L.P. Novo Nordisk A S Transaction History
Waterloo Capital, L.P.
- $833 Billion
- Q2 2024
A detailed history of Waterloo Capital, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Waterloo Capital, L.P. holds 3,365 shares of NVO stock, worth $362,174. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,365Holding current value
$362,174% of portfolio
0.06%Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,951Shares Held
320MCall Options Held
5.22MPut Options Held
5M-
Jennison Associates LLC21.2MShares$2.28 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.57 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.53 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.44 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.35 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $243B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...